- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1341EUR$1,500USD£1,146GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1787EUR$2,000USD£1,528GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1341EUR$1,500USD£1,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7105EUR$7,950USD£6,073GBP
- Report
- July 2025
- 350 Pages
Global
From €4423EUR$4,949USD£3,780GBP
- Report
- June 2025
- 200 Pages
Global
From €2493EUR$2,789USD£2,130GBP
- Report
- May 2024
- 134 Pages
Global
From €2680EUR$2,999USD£2,291GBP
€3574EUR$3,999USD£3,055GBP
- Report
- July 2024
- 162 Pages
Africa
From €2234EUR$2,500USD£1,910GBP
- Report
- July 2024
- 164 Pages
Global
From €2234EUR$2,500USD£1,910GBP
- Report
- December 2023
- 221 Pages
Global
From €3217EUR$3,599USD£2,749GBP
- Report
- May 2025
- 134 Pages
Global
From €16083EUR$17,995USD£13,746GBP
- Report
- December 2024
- 59 Pages
Global
From €3570EUR$3,995USD£3,052GBP
- Report
- August 2025
- 150 Pages
Global
From €2824EUR$3,160USD£2,414GBP
€3530EUR$3,950USD£3,017GBP
- Report
- August 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- July 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- March 2024
- 95 Pages
Europe
From €1341EUR$1,500USD£1,146GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1341EUR$1,500USD£1,146GBP
- Report
- March 2024
- 91 Pages
North America
From €1341EUR$1,500USD£1,146GBP
- Report
- March 2024
- 97 Pages
Middle East, Africa
From €1341EUR$1,500USD£1,146GBP
![Loading Indicator](/images/loading.gif")
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more
![º¬Ðß²ÝÊÓƵ](/images/logo.svg"){kind=logo}
![º¬Ðß²ÝÊÓƵ](/images/logo-research-and-markets-print.png"){kind=logo}